Advertisement
Advertisement
ADAG
Adagene Inc. - ADR
3.69
USDSponsored
+0.11
+3.07%
May 08, 15:59 UTC -4
Closed
After-Market
3.67
-0.02
-0.68%
ADAG Earnings Reports
Positive Surprise Ratio
ADAG beat 0 of 2 last estimates.
0%
Next Report
Date of Next Report
Aug 10, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.14
Implied change from Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q2 25 (Revenue/ EPS)
--
/-64.10%
Adagene Inc. - ADR earnings per share and revenue
On Apr 01, 2026, ADAG reported earnings of -- USD per share (EPS) for Q4 25, -- the estimate of -0.19 USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -7.91% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.14 USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ANI Pharmaceuticals, Inc.
Report Date
May 08, 2026 For Q1 26
Estimate
$1.33
Actual
$2.04
Surprise
+54.04%
Harmony Biosciences Holdings, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.72
Actual
$0.55
Surprise
-24.16%
CytomX Therapeutics, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.12
Actual
-$0.10
Surprise
+18.83%
Tectonic Therapeutic, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$1.20
Actual
-$1.34
Surprise
-11.07%
ALX Oncology Holdings Inc. Common Stock
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.17
Surprise
+24.24%
Entera Bio Ltd. Ordinary Shares
Report Date
May 08, 2026 For Q1 26
Estimate
-$0.15
Actual
-$0.07
Surprise
+54.25%
argenx SE - ADR
Report Date
May 07, 2026 For Q1 26
Estimate
$5.47
Actual
$5.52
Surprise
+0.86%
Arrowhead Research Corporation
Report Date
May 07, 2026 For Q2 26
Estimate
-$1.16
Actual
-$0.93
Surprise
+20.32%
ImmunityBio, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.09
Surprise
-26.05%
Stoke Therapeutics, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.84
Actual
-$0.79
Surprise
+6.34%
FAQ
What were Adagene Inc. - ADR's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Adagene Inc. - ADR reported EPS of --, missing estimates by --, and revenue of --, 0% as expectations.
How did the market react to Adagene Inc. - ADR's Q4 2025 earnings?
The stock price moved down -7.91%, changed from $3.92 before the earnings release to $3.61 the day after.
When is Adagene Inc. - ADR expected to report next?
The next earning report is scheduled for Aug 10, 2026.
What are the forecasts for Adagene Inc. - ADR's next earnings report?
Based on 3
analysts, Adagene Inc. - ADR is expected to report EPS of -$0.14 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement